TY - JOUR
T1 - A core-shell nanomaterial with endogenous therapeutic and diagnostic functions
AU - Patra, Chitta Ranjan
AU - Jing, Ying
AU - Xu, Yun Hao
AU - Bhattacharya, Resham
AU - Mukhopadhyay, Debabrata
AU - Glockner, James F.
AU - Wang, Jian Ping
AU - Mukherjee, Priyabrata
N1 - Funding Information:
Acknowledgment This work is supported by STATE-1 (MEDICA), CA135011, CA136494 grant to PM. This work is also supported by National Science Foundation BME 0730825, NSF NNIN program, the Medical Device Center of Institute of Engineering in Medicine and Center for Nanostructures Application at University of Minnesota and Minnesota Mayo Nanotechnology Partnership for JPW.
PY - 2010/12
Y1 - 2010/12
N2 - In the present communication, we report the fabrication of a unique core-shell inorganic nanomaterial with potential therapeutic and diagnostic functions. It contains an iron-cobalt (FeCo) core that demonstrates magnetic resonance imaging (MRI) contrast property and a thin nanoshell of gold that inhibits the function of a pro- angiogenic growth factor, VEGF165. Au(FeCo) core-shell nanomaterials are fabricated in the gas phase and characterized using transmission electron microscopy, energy dispersive spectrum, inductively coupled plasma analysis, and MRI. Inhibition of VEGF165 function by Au(FeCo) is demonstrated against VEGF165/VPF-induced signaling cascades and proliferation of human umbilical vein endothelial cells (HUVECs). The self-contrast property of Au (FeCo) is determined in vitro by MRI after incubating HUVECs with Au(FeCo), demonstrating intrinsic contrast property of this potentially therapeutic nanomaterial. In brief, we report here the successful fabrication of an inorganic core-shell nanomaterial with potential therapeutic and diagnostic functions. It inhibits the function of VEGF165 and functions as a MRI contrast agent.
AB - In the present communication, we report the fabrication of a unique core-shell inorganic nanomaterial with potential therapeutic and diagnostic functions. It contains an iron-cobalt (FeCo) core that demonstrates magnetic resonance imaging (MRI) contrast property and a thin nanoshell of gold that inhibits the function of a pro- angiogenic growth factor, VEGF165. Au(FeCo) core-shell nanomaterials are fabricated in the gas phase and characterized using transmission electron microscopy, energy dispersive spectrum, inductively coupled plasma analysis, and MRI. Inhibition of VEGF165 function by Au(FeCo) is demonstrated against VEGF165/VPF-induced signaling cascades and proliferation of human umbilical vein endothelial cells (HUVECs). The self-contrast property of Au (FeCo) is determined in vitro by MRI after incubating HUVECs with Au(FeCo), demonstrating intrinsic contrast property of this potentially therapeutic nanomaterial. In brief, we report here the successful fabrication of an inorganic core-shell nanomaterial with potential therapeutic and diagnostic functions. It inhibits the function of VEGF165 and functions as a MRI contrast agent.
KW - Angiogenesis
KW - Core-shell
KW - Diagnostics
KW - Gold
KW - Nanoparticle
KW - Therapeutics
UR - http://www.scopus.com/inward/record.url?scp=79952632096&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952632096&partnerID=8YFLogxK
U2 - 10.1007/s12645-010-0002-4
DO - 10.1007/s12645-010-0002-4
M3 - Article
AN - SCOPUS:79952632096
SN - 1868-6958
VL - 1
SP - 13
EP - 18
JO - Cancer Nanotechnology
JF - Cancer Nanotechnology
IS - 1-6
ER -